Pre-Open Stock Movers 12/08: (LXRX) (SFIX) (SMAR) Higher; (PEN) (CONN) (MRNS) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
GrowGeneration Corp. (GRWG) Prices 5M Share Upsized Common Offering at $30/Sh
December 9, 2020 7:04 AM ESTGrowGeneration Corp. (NASDAQ: GRWG) today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at an offering price of $30.00 per share (the "Offering"). GrowGen expects the gross proceeds from the Offering to be approximately $150 million, before deducting the underwriting... More
ATARA Biotherapeutics (ATRA) Prices 5.102M Share Common Offering at $24.50/Sh
December 9, 2020 6:11 AM ESTAtara Biotherapeutics, Inc. (NASDAQ: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T- cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced the pricing of an underwritten public offering of 5,102,041 shares of its common stock at a price to the public of $24.50 per share and, to... More
Sutro Biopharma Inc. (STRO) Prices 6M Share Common Offering at $21/Sh
December 9, 2020 6:10 AM ESTSutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a price to the public of $21.00 per share. The gross proceeds... More
Marinus Pharma (MRNS) Prices 5M Share Common Offering for Gross Proceeds of $70M
December 8, 2020 9:44 AM ESTMarinus Pharmaceuticals, Inc. (NASDAQ: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the pricing of an underwritten public offering of 5 million shares of its common stock for gross proceeds of $70 million, before deducting the underwriting discounts and commissions and other estimated offering expenses... More
